AlphaGrep UK’s Oracle ORCL Stock Holding History

AlphaGrep UK’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$380K	Buy	2,590 +794	+44%	+$144K	0.11%	347
2026 Q1	$264K	Buy	+1,796	New	+$292K	0.08%	570

Other funds holding ORCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AlphaGrep UK's ORCL Position: Q2 2026 in Review

AlphaGrep UK increased its Oracle (ORCL) stake by 44% in Q2 2026, buying an estimated $144K and bringing the position to 2,590 shares worth $380K. The position accounts for 0.11% of the portfolio, ranked #347.

AlphaGrep UK first reported a position in ORCL in Q1 2026 and has held it in 2 quarters since. 3,362 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

AlphaGrep UK held 2,590 shares of Oracle worth $380K as of Q2 2026.
AlphaGrep UK bought 794 Oracle shares in Q2 2026, an estimated $144K.
Oracle made up 0.11% of AlphaGrep UK's portfolio in Q2 2026, its #347 holding.
AlphaGrep UK first reported a position in Oracle in Q1 2026 and has held it in 2 quarters since.
3,362 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.